IL155249A0 - Methods of isolating bipotent hepatic progenitor cells - Google Patents

Methods of isolating bipotent hepatic progenitor cells

Info

Publication number
IL155249A0
IL155249A0 IL15524900A IL15524900A IL155249A0 IL 155249 A0 IL155249 A0 IL 155249A0 IL 15524900 A IL15524900 A IL 15524900A IL 15524900 A IL15524900 A IL 15524900A IL 155249 A0 IL155249 A0 IL 155249A0
Authority
IL
Israel
Prior art keywords
progenitors
cells
hepatic
antigen
cell
Prior art date
Application number
IL15524900A
Other languages
English (en)
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of IL155249A0 publication Critical patent/IL155249A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15524900A 2000-10-03 2000-10-03 Methods of isolating bipotent hepatic progenitor cells IL155249A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/027429 WO2002028997A2 (fr) 2000-10-03 2000-10-03 Procedes permettant d'isoler des cellules souches hepatiques bipotentes

Publications (1)

Publication Number Publication Date
IL155249A0 true IL155249A0 (en) 2003-11-23

Family

ID=21741847

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15524900A IL155249A0 (en) 2000-10-03 2000-10-03 Methods of isolating bipotent hepatic progenitor cells
IL155249A IL155249A (en) 2000-10-03 2003-04-03 Population of cells enriched in isolated bipotent hepatic progenitors and methods for obtaining the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155249A IL155249A (en) 2000-10-03 2003-04-03 Population of cells enriched in isolated bipotent hepatic progenitors and methods for obtaining the same

Country Status (11)

Country Link
EP (1) EP1325112B1 (fr)
JP (1) JP2004510432A (fr)
CN (1) CN1258589C (fr)
AT (1) ATE510905T1 (fr)
AU (2) AU7858200A (fr)
CA (1) CA2424781C (fr)
DK (1) DK1325112T3 (fr)
ES (1) ES2367005T3 (fr)
HK (1) HK1054569B (fr)
IL (2) IL155249A0 (fr)
WO (1) WO2002028997A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187133A1 (en) 1999-10-01 2002-12-12 Hiroshi Kubota Methods of isolating bipotent hepatic progenitor cells
CN1461341A (zh) * 2000-10-03 2003-12-10 北卡罗来纳大学 肝祖先细胞克隆生长的方法
KR100947911B1 (ko) 2001-03-27 2010-03-17 버텍스 파마슈티칼스 인코포레이티드 Ｈｃｖ 감염에 유용한 조성물 및 방법
US7211404B2 (en) 2001-06-22 2007-05-01 Stem Cells, Inc. Liver engrafting cells, assays, and uses thereof
CA2553303C (fr) * 2004-01-14 2014-06-10 Novahep Ab Cellules progenitrices hepatiques humaines et procedes d'utilisation correspondants
CN102083967B (zh) * 2007-07-20 2013-05-15 塞拉提斯股份公司 经由定型内胚层(DE-hep)衍生自人胚泡衍生干细胞的新肝细胞群体
EP3321286B1 (fr) * 2011-08-23 2021-01-06 Roche Glycart AG Molécules bispécifiques de liaison à l'antigène activant des lymphocytes t
PL3140393T3 (pl) * 2014-08-28 2023-11-06 Cellaïon SA Sposób wytwarzania komórek progenitorowych dorosłej wątroby
SG11201704291QA (en) * 2014-11-26 2017-06-29 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
JP6704617B2 (ja) * 2016-01-29 2020-06-03 北海道公立大学法人 札幌医科大学 小型肝細胞の継代培養方法
CN109385394A (zh) * 2018-11-02 2019-02-26 大连理工大学 一种提取、分离和培养同体异种肝原代细胞的方法
AU2019398753A1 (en) * 2018-12-14 2021-08-05 Promethera Therapeutics Sa Cell composition comprising liver progenitor cells expressing HLA-E

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
KR100873690B1 (ko) * 1999-01-19 2008-12-12 유니버시티 오브 노스캐롤라이나 앳 채플 힐 인간 간 전구세포

Also Published As

Publication number Publication date
CA2424781C (fr) 2018-11-06
WO2002028997A2 (fr) 2002-04-11
CN1258589C (zh) 2006-06-07
EP1325112B1 (fr) 2011-05-25
WO2002028997A3 (fr) 2002-09-12
HK1054569A1 (en) 2003-12-05
EP1325112A2 (fr) 2003-07-09
CA2424781A1 (fr) 2002-04-11
CN1461340A (zh) 2003-12-10
ES2367005T3 (es) 2011-10-27
JP2004510432A (ja) 2004-04-08
DK1325112T3 (da) 2011-09-12
AU2000278582B2 (en) 2007-08-30
AU7858200A (en) 2002-04-15
IL155249A (en) 2011-12-29
ATE510905T1 (de) 2011-06-15
HK1054569B (en) 2012-03-02

Similar Documents

Publication Publication Date Title
Wong et al. Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus
AU7858200A (en) Methods of isolating bipotent hepatic progenitor cells
Shafritz et al. Liver stem cells and model systems for liver repopulation
Driscoll et al. Establishment of immortalized alveolar type II epithelial cell lines from adult rats
Lawson et al. Stem cells in prostate cancer initiation and progression
Meuleman et al. Human marrow mesenchymal stem cell culture: serum‐free medium allows better expansion than classical α‐MEM medium
Austin et al. Hepatic regeneration from hematopoietic stem cells
de Pooter et al. In vitro generation of T lymphocytes from embryonic stem cell–derived prehematopoietic progenitors
Bonilla et al. Functional neural stem cells derived from adult bone marrow
WO2003104411A3 (fr) Systeme de foie bioartificiel
Cordeiro-Spinetti et al. Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation
ATE449837T1 (de) Abstammungs-spezifische zellen und vorläuferzellen
WO2021041443A3 (fr) Diversification de lignées mésodermiques d'organoïdes
DE60040782D1 (de) Menschliche leber-vorläuferzellen
WO2001081549A3 (fr) Cellules hepatocytes de lignee derivees de cellules souches pluripotentielles
JP2012507304A5 (fr)
BRPI0710339A2 (pt) método de modulação de uma reação imunólogica, método de redução e extrato
SI1759536T1 (sl) Tehnike in vitro za uporabo pri sistemskih celicah
LeBleu et al. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome
Reynolds et al. Lung epithelial healing: a modified seed and soil concept
Pouliot et al. Optimization of a transplant model to assess skin reconstitution from stem cell‐enriched primary human keratinocyte populations
Shafritz Rat liver stem cells: prospects for the future
Poliakova et al. Presence of nonhematopoietic side population cells in the adult human and nonhuman primate pancreas
Islam et al. Functional characterization of cell hybrids generated by induced fusion of primary porcine mesenchymal stem cells with an immortal murine cell line
SG11201806182RA (en) Methods of producing viruses